MGX Minerals' Flagship Mining Project Awaits Lease Issuance

Spotlight Companies |

Waiting for approval to pursue one’s goals is a universal stress. After weeks or months of effort and careful attention to every requirement and detail, there is inevitably one person or committee that can either mark the project complete, or send it back to the drawing board. Canadian mining company MGX Minerals Inc (XMG:CNX) is currently in the middle of this arduous process, as they await a pending approval in the crucial last stage of their major mining project.

MGX Minerals’ flagship Driftwood Creek project has been submitted in the final step of mining lease issuance to the British Columbia Land Title and Survey Authority. The project was completed, certified and is awaiting review by the B.C. Surveyor General and the B.C. Ministry of Energy and Mines.

Currently controlling the majority of known magnesite occurrences in British Columbia, the Vancouver-based mining company’s goal for the project is to construct a quarry mine processing plant to produce magnesium oxide. Driftwood Creek is located in the Brisco-Driftwood mining district of Southeastern British Columbia.

One Step Closer to Producing a Vital Product

Continued production of magnesium oxide ensures that consumers will have access to over-the-counter medicines that help treat acid indigestion, heartburn, and low magnesium levels.

Having completed the Driftwood Creek Phase II drilling in just over a month, it’s hard to play the waiting game. However, in MGX Minerals’ case, the multiple channels of approval will have been worth the trouble, as the issuance of this mining lease will allow MGX Minerals to take a leading role in providing various medical companies with a mineral that is absolutely essential to our health.

For more information, please visit the company’s website at www.mgxminerals.com.

Disclosure: In the purview of Section 17(B) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention the fact that Equities.com, Inc. may be compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker, broker dealer, investment advisor, analyst, investment banker or underwriter. All profiles are based on information that is available to the public. The information contained herein should not be considered to be all-inclusive and is not guaranteed by Equities.com to be free from misstatement or errors. Readers are reminded to do their own due diligence when researching any companies mentioned on this website.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

GoCoin

Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…

Lyft

Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…